Biomaterials elicit a distinct inflammatory response leading to the formation of destructive foreign body giant cells (FBGC) that participate in the encapsulating foreign body response (FBR). We have described the participation of the chemokine MCP1 in the formation of FBGC and fibrotic encapsulation; the latter in a tissue- specific manner. Specifically, we found that MCP1 is critical for FBGC formation in both subcutaneous (SC) and intraperitoneal (IP) implantation models and for fibrosis only in the latter. Our findings prompted us to investigate the activation phenotype of WT and MCP1 KO macrophages in the context of the FBR IP. In preliminary studies, we have discovered a reduction in the levels of TNF-? and low activation of the NF?B pathway in vitro and in vivo. Moreover, these defects were associated with reduced levels of TGF- and attenuated fibrosis. Therefore, our findings suggest that MCP1 is a critical determinant of macrophage polarization/activation in the FBR. To gain greater inside into the mechanism of biomaterial-induced macrophage activation and fusion, we initiated high throughput analysis of cDNA and micro inhibitory RNA (miRNA) arrays with a focus on identifying genes and miRNAs that are differentially regulated in WT and MCP1 macrophages. In addition, we have explored macrophage signaling by focusing on activation of kinases and preliminary studies indicate a defect in ERK1/2 activation in MCP1 KO macrophages. In this application, we propose studies to explore and exploit macrophage activation and identify mechanistic links between this process and the progression of the FBR in various tissues. In addition, we aim to expand and translate some of our findings into bioengineering approaches that should provide proof-of-principle for the modulation of macrophage phenotype as a strategy to attenuate the FBR. Accordingly, the specific aims of this application are: 1) to test the hypothesis the MCP1-specific signaling modulates the function of biomaterial-adherent macrophages; 2) to test the hypothesis that biomaterial-induced macrophage activation is a critical determinant of implant fibrosis; and 3) to test the hypothesis that biomaterial-induced macrophage activation and/or fusion is regulated by specific miRNAs.
Implantation of biomaterials, devices, and tissue engineered constructs into vascularized tissues elicits an inflammatory response the can lead to implant failure. A hallmark of this response is the fusion of inflammatory cells on the implant surface to form multinucleated giant cells that can be destructive. In addition, the inflammatory response leads to the eventual encapsulation of the implant resulting in lack of integration. In this application we propose to explore the molecular signals that regulate the activation of inflammatory cells and the formation of giant cells and develop biomaterials with the inherent ability to modulate the inflammatory response they elicit. Completion of this project should lead to a greater understanding of the events at the interface between living tissues and biomaterials.
| Loye, Ayomiposi M; Kinser, Emily R; Bensouda, Sabrine et al. (2018) Regulation of Mesenchymal Stem Cell Differentiation by Nanopatterning of Bulk Metallic Glass. Sci Rep 8:8758 |
| MacLauchlan, Susan C; Calabro, Nicole E; Huang, Yan et al. (2018) HIF-1? represses the expression of the angiogenesis inhibitor thrombospondin-2. Matrix Biol 65:45-58 |
| Morris, Aaron H; Stamer, Danielle K; Kunkemoeller, Britta et al. (2018) Decellularized materials derived from TSP2-KO mice promote enhanced neovascularization and integration in diabetic wounds. Biomaterials 169:61-71 |
| Shayan, Mahdis; Padmanabhan, Jagannath; Morris, Aaron H et al. (2018) Nanopatterned bulk metallic glass-based biomaterials modulate macrophage polarization. Acta Biomater 75:427-438 |
| Kunkemoeller, Britta; Kyriakides, Themis R (2017) Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition. Antioxid Redox Signal 27:823-838 |
| Padmanabhan, Jagannath; Augelli, Michael J; Cheung, Bettina et al. (2016) Regulation of cell-cell fusion by nanotopography. Sci Rep 6:33277 |
| Sawyer, Andrew J; Kyriakides, Themis R (2016) Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Adv Drug Deliv Rev 97:56-68 |
| Morris, Aaron H; Chang, Julie; Kyriakides, Themis R (2016) Inadequate Processing of Decellularized Dermal Matrix Reduces Cell Viability In Vitro and Increases Apoptosis and Acute Inflammation In Vivo. Biores Open Access 5:177-87 |
| Moore, Laura Beth; Sawyer, Andrew J; Saucier-Sawyer, Jennifer et al. (2016) Nanoparticle delivery of miR-223 to attenuate macrophage fusion. Biomaterials 89:127-35 |
| Padmanabhan, Jagannath; Kyriakides, Themis R (2015) Nanomaterials, inflammation, and tissue engineering. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7:355-70 |
Showing the most recent 10 out of 42 publications
